Polymorphism in the promoter region of the klotho gene (G-395A) is associated with early dysfunction in vascular access in hemodialysis patients
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Vascular access dysfunction is an important cause of morbidity and mortality in hemodialysis (HD) patients. Recent studies have shown that a klotho gene mutation is related to endothelial dysfunction, thrombosis, and arteriosclerosis, which are regarded as causes of vascular access dysfunction. We investigated the relationship between the klotho G-395A polymorphism and early dysfunction in vascular access in HD patients. Methods: Patients who underwent vascular access operations between 1999 and 2002 were enrolled (n=126). Genotyping was performed by allelic discrimination using a 5’-nuclease polymerase chain reaction assay. Clinical data that could be relevant to access dysfunction were obtained from medical records. Early dysfunction of vascular access was defined as the need for any angioplastic or surgical intervention to correct or replace a poorly or nonfunctioning vascular access within 1 year and at least 8 weeks after initial access placement. Results: Of the 126 patients, the genotype frequency of G-395A was 72.2% for GG (n=91), 24.6% for GA (n=31), and 3.2% for AA (n=4), and the frequency of minor allele was 0.155. Clinical data were similar between the two groups, divided according to the status of the A allele. Early dysfunction occurred in 34 (27.0%) of patients, but it occurred at a significantly higher rate in A allele carriers (45.7%, 16/35) than in noncarriers (19.8%, 18/91; p=0.003). Conclusions: Our results suggest that the klotho G-395A polymorphism could be a risk factor for early dysfunction of vascular access in HD patients.
Abstract
Background/Aims: Vascular access dysfunction is an important cause of morbidity and mortality in hemodialysis (HD) patients. Recent studies have shown that a klotho gene mutation is related to endothelial dysfunction, thrombosis, and arteriosclerosis, which are regarded as causes of vascular access dysfunction. We investigated the relationship between the klotho G-395A polymorphism and early dysfunction in vascular access in HD patients. Methods: Patients who underwent vascular access operations between 1999 and 2002 were enrolled (n=126). Genotyping was performed by allelic discrimination using a 5’-nuclease polymerase chain reaction assay. Clinical data that could be relevant to access dysfunction were obtained from medical records. Early dysfunction of vascular access was defined as the need for any angioplastic or surgical intervention to correct or replace a poorly or nonfunctioning vascular access within 1 year and at least 8 weeks after initial access placement. Results: Of the 126 patients, the genotype frequency of G-395A was 72.2% for GG (n=91), 24.6% for GA (n=31), and 3.2% for AA (n=4), and the frequency of minor allele was 0.155. Clinical data were similar between the two groups, divided according to the status of the A allele. Early dysfunction occurred in 34 (27.0%) of patients, but it occurred at a significantly higher rate in A allele carriers (45.7%, 16/35) than in noncarriers (19.8%, 18/91; p=0.003). Conclusions: Our results suggest that the klotho G-395A polymorphism could be a risk factor for early dysfunction of vascular access in HD patients.
참고문헌 (27)
- Feldman HI, "Hemodialysis vascular access morbidity", JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 7, pp.523~535 (1996)
- Woods JD, "The impact of vascular access for haemodialysis on patient morbidity and mortality", Nephrology Dialysis Transplantation, 12, pp.657~659 (1997)
- Zibari GB, "Complication from permanent hemodialysis vascular access", Surgery, 104, pp.681~686 (1988)
- Palder SB, "Vascular access for hemodialysis: patency rates and results of revision", ANNALS OF SURGERY, 202, pp.235~239 (1985)
- Wong V, "Factors associated with early failure of arteriovenous fistulae for haemodialysis access", European Journal of Vascular and Endovascular Surgery, 12, pp.207~213 (1996)
- 문수연, "혈액 투석 환자에서 동정맥루의 조기폐쇄와 관련된 위험인자 분석", The Korean Journal of Nephrology, 25(3), pp.423~430 (2006), 대한신장학회
- 김영옥, "요골동맥-요측부정맥 동정맥루의 조기 기능이상:혈관 확장술의 1차 및 누적 개통률", The Korean Journal of Nephrology, 22(4), pp.11~419 (2003), 대한신장학회
- Kim YO, "Access blood flow as a predictor of early failures of native arteriovenous fistulas in hemodialysis patients", AMERICAN JOURNAL OF NEPHROLOGY, 21, pp.221~225 (2001)
- De Marchi S, "Risk factors for vascular disease and arteriovenous fistula dysfunction in hemodialysis patients", JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 7, pp.1169~1177 (1996)
- Girndt M, "Gene polymorphism association studies in dialysis: vascular access", Seminars in Dialysis, 20, pp.63~67 (2007)
- 김영옥, "비당뇨병성 혈액투석 환자에서 허혈성 심질환이 동정맥루 조기 기능부전에 끼치는 영향", The Korean Journal of Nephrology, 23(1), pp.101~107 (2004), 대한신장학회
- Kim YO, "Hemodialysis vascular accss dysfunction: a cellular and molecular viewpoint", The Korean Journal of Nephrology, 25, pp.S559~S562 (2006), 대한신장학회
- Kurosu H, "Suppression of aging in mice by the hormone Klotho", Science, 309, pp.1829~1833 (2005)
- Kuro-o M, "Mutation of the mouse klotho gene leads to a syndrome resembling ageing", Nature, 390, pp.45~51 (1997)
- Arking DE, "Association between a functional variant of the KLOTHO gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity", CIRCULATION RESEARCH, 96, pp.412~418 (2005)
- Arking DE, "KLOTHO allele status and the risk of early-onset occult coronary artery disease", AMERICAN JOURNAL OF HUMAN GENETICS, 72, pp.1154~1161 (2003)
- 이은정, "한국인 성인에서 KLOTHO 유전자다형성과 관상동맥 질환의 연관성", 대한내과학회지, 70(3), pp.268~276 (2006), 대한내과학회
- Kim Y, "Klotho is a genetic risk factor for ischemic stroke caused by cardioembolism in Korean females", NEUROSCIENCE LETTERS, 407, pp.189~194 (2006)
- Kawano K, "Klotho gene polymorphisms associated with bone density of aged postmenopausal women", Journal of Bone and Mineral Research, 17, pp.1744~1751 (2002)
- Nagai R, "Endothelial dysfunction in the klotho mouse and downregulation of klotho gene expression in various animal models of vascular and metabolic diseases", CELLULAR AND MOLECULAR LIFE SCIENCES, 57, pp.738~746 (2000)
- Saito Y, "In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome", Biochemical and Biophysical Research Communications, 276, pp.767~772 (2000)
- Takeshita K, "Increased expression of plasminogen activator inhibitor-1 with fibrin deposition in a murine model of aging, "Klotho" mouse", SEMINARS IN THROMBOSIS AND HEMOSTASIS, 28, pp.545~554 (2002)
- Astor BC, "Relation between gender and vascular access complications in hemodialysis Youngsu Kim, et al. klotho polymorphism and early vascular access dysfunction 207 patients", AMERICAN JOURNAL OF KIDNEY DISEASES, 36, pp.1126~1134 (2000)
- Ernandez T, "Risk factors for early failure of native arteriovenous fistulas", NEPHRON CLINICAL PRACTICE, 101, pp.C39~C44 (2005)
- De Marchi S, "Risk factors for vascular disease and arteriovenous fistula dysfunction in hemodialysis patients", JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 7, pp.1169~1177 (1996)
- Deary IJ, "KLOTHO genotype and cognitive ability in childhood and old age in the same individuals", NEUROSCIENCE LETTERS, 378, pp.22~27 (2005)
- Weiss LA, "The sex-specific genetic architecture of quantitative traits in humans", NATURE GENETICS, 38, pp.218~222 (2006)